Both are injectable peptide-based therapies targeting multiple hormonal pathways cagrilintide as a long-acting amylin analogue, and retatrutide as a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors
MethycOBAL Injection is generally safe and does not usually cause any common side effects
"Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes"
Symptoms of overmedication include heart palpitations, anxiety, tremor, excessive sweating, difficulty sleeping, and unintentional additional weight loss
Weight loss treatment options include everything from prescription drugs such as Ozempic and Wegovy to compounded and GLP-1s
Third, the phase 2 diabetes trial was small including only 30-31 patients in each group [10]